A detailed history of Samalin Investment Counsel, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 1,892 shares of ZTS stock, worth $331,364. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,892
Previous 1,891 0.05%
Holding current value
$331,364
Previous $327,000 12.84%
% of portfolio
0.17%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $172 - $196
1 Added 0.05%
1,892 $369,000
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $275,216 - $338,167
1,891 New
1,891 $327,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Samalin Investment Counsel, LLC Portfolio

Follow Samalin Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.